GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CellaVision AB (OTCPK:CLVSF) » Definitions » Earnings Yield (Joel Greenblatt) %

CLVSF (CellaVision AB) Earnings Yield (Joel Greenblatt) % : 5.29% (As of Mar. 2025)


View and export this data going back to 2010. Start your Free Trial

What is CellaVision AB Earnings Yield (Joel Greenblatt) %?

CellaVision AB's Enterprise Value for the quarter that ended in Mar. 2025 was $444.13 Mil. CellaVision AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 was $19.34 Mil. CellaVision AB's Earnings Yield (Joel Greenblatt) for the quarter that ended in Mar. 2025 was 5.29%.

The historical rank and industry rank for CellaVision AB's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:

CLVSF' s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: 1.12   Med: 2.56   Max: 6.77
Current: 4.58

During the past 13 years, the highest Earnings Yield (Joel Greenblatt) of CellaVision AB was 6.77%. The lowest was 1.12%. And the median was 2.56%.

CLVSF's Earnings Yield (Joel Greenblatt) % is ranked better than
72.18% of 859 companies
in the Medical Devices & Instruments industry
Industry Median: 0.31 vs CLVSF: 4.58

Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.

A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. CellaVision AB's Forward Rate of Return (Yacktman) % for the quarter that ended in Mar. 2025 was 11.94%. The Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.


CellaVision AB Earnings Yield (Joel Greenblatt) % Historical Data

The historical data trend for CellaVision AB's Earnings Yield (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CellaVision AB Earnings Yield (Joel Greenblatt) % Chart

CellaVision AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Earnings Yield (Joel Greenblatt) %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.56 2.06 2.76 3.35 3.53

CellaVision AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Earnings Yield (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.38 3.25 2.87 3.53 5.29

Competitive Comparison of CellaVision AB's Earnings Yield (Joel Greenblatt) %

For the Medical Devices subindustry, CellaVision AB's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CellaVision AB's Earnings Yield (Joel Greenblatt) % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, CellaVision AB's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where CellaVision AB's Earnings Yield (Joel Greenblatt) % falls into.


;
;

CellaVision AB Earnings Yield (Joel Greenblatt) % Calculation

In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.

CellaVision ABs Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Dec. 2024 is calculated as

Earnings Yield (Joel Greenblatt)=EBIT/Enterprise Value
=16.272/606.72706
=2.68 %

CellaVision AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $19.34 Mil.



CellaVision AB  (OTCPK:CLVSF) Earnings Yield (Joel Greenblatt) % Explanation

Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.

Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.


Be Aware

Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.

Forward Rate of Return (Yacktman) % based on Don Yacktman's definition is a better measure of the expected rate of return for a stock.


CellaVision AB Earnings Yield (Joel Greenblatt) % Related Terms

Thank you for viewing the detailed overview of CellaVision AB's Earnings Yield (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.


CellaVision AB Business Description

Traded in Other Exchanges
Address
Mobilvagen 12, Lund, SWE, 22362
CellaVision AB is engaged in the business of supplying digital solutions for blood and body fluid analysis. Its solutions are based on digital image analysis technology, artificial intelligence, and information technology. The firm's product portfolio consists of CellaVision peripheral blood application, CellaVision advanced RBC application, and CellaVision remote review software. Its customers include mainly large hospital laboratories and commercial laboratories in North America, Europe and China, and Japan. The company derives the majority of its revenue from the sale of analyzers or software.

CellaVision AB Headlines

From GuruFocus

Q3 2022 CellaVision AB Earnings Call Transcript

By GuruFocus Research 03-03-2024

Q3 2019 CellaVision AB Earnings Call Transcript

By GuruFocus Research 03-03-2024

Q3 2024 CellaVision AB Earnings Call Transcript

By GuruFocus News 10-25-2024

Q2 2019 CellaVision AB Earnings Call Transcript

By GuruFocus Research 03-03-2024

3 Scandinavian Companies With Strong Margin Growth

By James Li James Li 12-01-2020

Q4 2022 CellaVision AB Earnings Call Transcript

By GuruFocus Research 03-03-2024

Q1 2022 CellaVision AB Earnings Call Transcript

By GuruFocus Research 03-03-2024

Q4 2024 CellaVision AB Earnings Call Transcript

By GuruFocus News 02-08-2025